Rocket PharmaceuticalsNASDAQ: RCKT: Developing gene therapies for rare and life-threatening diseases.
10+ YOE5+ MgmtBachelor's degree required; 10 years clinical trial experience with minimum 5 years managing full trial lifecycle, direct monitoring/site management, EDC (Rave)/CTMS/eTMF (Veeva) experience; gene therapy and regulatory filing experience preferred.
Rocket PharmaceuticalsNASDAQ: RCKT: Developing gene therapies for rare and life-threatening diseases.
10+ YOE5+ MgmtBachelor's degree required; 10 years clinical trial experience with minimum 5 years managing trials, direct site monitoring experience, knowledge of ICH/GCP, EDC (Rave), CTMS, eTMF (Veeva), vendor/CRO oversight, and strong project management skills.
Kymera TherapeuticsNASDAQ: KYMR: Develops targeted protein degradation medicines to treat human diseases.
3+ YOEBachelor of Science in Life Sciences; 3+ years as a CTM or 5+ years as a Sr. CTM; experience on large global Phase 2 trials; strong PM, regulatory knowledge, and communication skills.
ErascaNASDAQ: ERAS: Developing precision oncology medicines to treat cancer patients.
5+ YOE5+ years (Clinical Trial Manager) or 7+ years (Senior) oncology clinical operations experience; preferred bachelor's in life sciences or allied health; experience with trial set-up, monitoring, close-out, vendor management, ICH-GCP and electronic data capture.
5+ YOEBachelor's in life sciences required, 5+ years clinical trial management experience in pharma/biotech/CRO, global trial and CRO/vendor oversight experience, Phase 2/3 and oncology preferred, strong project management and communication skills.
Kailera Therapeutics: Developing clinical-stage injectable and oral therapies for obesity.
8+ YOE8+ years clinical trial experience managing CROs and vendors, deep GCP/ICH knowledge, strong organizational and communication skills, ability to lead cross-functional teams and travel as needed.
Impulse Dynamics: Developer of implantable cardiac contractility modulation therapy systems.
4+ YOEBachelor's in scientific/clinical field, 4+ years clinical operations/clinical trial management experience (2 years for Associate level), IDE trial experience required, FDA/ICH-GCP knowledge, project management and vendor oversight skills.
Microsoft Office, clinical trial management systems
Structure TherapeuticsNASDAQ: GPCR: Developing oral small molecule medicines for chronic diseases
7+ YOE3+ Mgmt7+ years industry experience with 3+ years study management; Bachelor's degree or equivalent; experience managing global trials, CROs, budgets, and service providers; knowledge of ICH/GCP, FDA/EU regulations; MS Office; EDC/CTMS/eTMF experience; up to 30% travel.
EDC, CTMS, eTMF, Microsoft Outlook, Microsoft Word, Microsoft Excel, Microsoft PowerPoint
City Therapeutics: Developing next-generation RNA interference-based medicines for various diseases.
6+ YOEMinimum 6 years in clinical trial management in biotech/pharma; strong vendor/CRO management; knowledge of GCP/ICH regulatory requirements; strong PM skills; travel up to 15%.
Odyssey Therapeutics: Developing precision medicines for cancer and inflammatory diseases.
3+ YOEBachelor’s degree in life sciences; minimum 3 years in clinical trial management, including at least 1 year as a CTM; biotech experience; strong collaboration and project management; travel 25-35%.
Sagimet BiosciencesNasdaq: SGMT: Develops oral FASN inhibitor drugs for metabolic and inflammatory diseases.
10+ YOE3+ MgmtBachelor's in life sciences, 10+ years clinical operations, 3+ years leading trials, CRO/vendor oversight, knowledge of ICH-GCP/FDA/EMEA, GDPR, and experience across Phase 2/3 global trials.
AmbuNasdaq Copenhagen: AMBU B: Developing and manufacturing single-use endoscopes and medical devices.
3+ YOEBachelor's in a relevant scientific field, several years of clinical operations/clinical trial management experience in medical device/biotech, working knowledge of ISO 14155 and GCP, site management and monitoring experience, strong project and stakeholder management skills.
Entrada TherapeuticsNasdaq: TRDA: Develops medicines that target and treat previously inaccessible intracellular diseases.
7+ YOEBA/BS and 7+ years managing clinical trial activities, strong ICH/GCP knowledge, global trial and CRO/vendor oversight experience, excellent communication, and willingness to travel ~20%.